Literature DB >> 23504860

Decreasing incidence of late-stage breast cancer after the introduction of organized mammography screening in Italy.

Flavia Foca1, Silvia Mancini, Lauro Bucchi, Donella Puliti, Marco Zappa, Carlo Naldoni, Fabio Falcini, Maria L Gambino, Silvano Piffer, Maria E Sanoja Gonzalez, Fabrizio Stracci, Manuel Zorzi, Eugenio Paci.   

Abstract

BACKGROUND: After the introduction of a mammography screening program, the incidence of late-stage breast cancer is expected to decrease. The objective of the current study was to evaluate variations in the total incidence of breast cancer and in the incidence of breast cancers with a pathologic tumor (pT) classification of pT2 through pT4 after the introduction of mammography screening in 6 Italian administrative regions.
METHODS: The study area included 700 municipalities, with a total population of 692,824 women ages 55 to 74 years, that were targeted by organized mammography screening between 1991 and 2005. The year screening started at the municipal level (year 1) was identified. The years of screening were numbered from 1 to 8. The ratio of the observed 2-year, age-standardized (Europe) incidence rate to the expected rate (the incidence rate ratio [IRR]) was calculated. Expected rates were estimated assuming that the incidence of breast cancer was stable and was equivalent to that in the last 3 years before year 1.
RESULTS: The study was based on a total of 14,447 incident breast cancers, including 4036 pT2 through pT4 breast cancers. The total IRR was 1.35 (95% confidence interval, 1.03-1.41) in years 1 and 2, 1.16 (95% confidence interval, 1.10-1.21) in years 3 and 4, 1.14 (95% confidence interval, 1.08-1.20) in years 5 and 6, and 1.14 (95% confidence interval, 1.08-1.21) in years 7 and 8. The IRR for pT2 through pT4 breast cancers was 0.97 (95% confidence interval, 0.90-1.04) in years 1 and 2, 0.81 (95% confidence interval, 0.75-0.88) in years 3 and 4, 0.79 (95% confidence interval, 0.73-0.87) in years 5 and 6, and 0.71 (95% confidence interval, 0.64-0.79) in years 7 and 8.
CONCLUSIONS: A significant and stable decrease in the incidence of late-stage breast cancer was observed from the third year of screening onward, when the IRR varied between 0.81 and 0.71.
Copyright © 2013 American Cancer Society.

Entities:  

Mesh:

Year:  2013        PMID: 23504860     DOI: 10.1002/cncr.28014

Source DB:  PubMed          Journal:  Cancer        ISSN: 0008-543X            Impact factor:   6.860


  16 in total

1.  Mammography, Martin Yaffe, and me: response and appreciation.

Authors:  Constantine Kaniklidis
Journal:  Curr Oncol       Date:  2015-10       Impact factor: 3.677

2.  The burden of breast cancer from China to Italy.

Authors:  Alessia Levaggi; Francesca Poggio; Matteo Lambertini
Journal:  J Thorac Dis       Date:  2014-06       Impact factor: 2.895

3.  Factors associated with breast screening radiologists' annual mammogram reading volume in Italy.

Authors:  Doralba Morrone; Livia Giordano; Franca Artuso; Daniela Bernardi; Chiara Fedato; Alfonso Frigerio; Daniela Giorgi; Carlo Naldoni; Gianni Saguatti; Daniela Severi; Mario Taffurelli; Daniela Terribile; Leonardo Ventura; Lauro Bucchi
Journal:  Radiol Med       Date:  2016-03-31       Impact factor: 3.469

4.  Atti del 52° Congresso Nazionale: Società Italiana di Igiene, Medicina Preventiva e Sanità Pubblica (SItI).

Authors: 
Journal:  J Prev Med Hyg       Date:  2019-10-15

5.  Primary Breast Lymphoma in the United States: 1975-2013.

Authors:  Alexandra Thomas; Brian K Link; Sean Altekruse; Paul A Romitti; Mary C Schroeder
Journal:  J Natl Cancer Inst       Date:  2017-06-01       Impact factor: 13.506

6.  Detecting Germline PTEN Mutations Among At-Risk Patients With Cancer: An Age- and Sex-Specific Cost-Effectiveness Analysis.

Authors:  Joanne Ngeow; Chang Liu; Ke Zhou; Kevin D Frick; David B Matchar; Charis Eng
Journal:  J Clin Oncol       Date:  2015-07-13       Impact factor: 44.544

7.  Cumulative Advanced Breast Cancer Risk Prediction Model Developed in a Screening Mammography Population.

Authors:  Karla Kerlikowske; Shuai Chen; Marzieh K Golmakani; Brian L Sprague; Jeffrey A Tice; Anna N A Tosteson; Garth H Rauscher; Louise M Henderson; Diana S M Buist; Janie M Lee; Charlotte C Gard; Diana L Miglioretti
Journal:  J Natl Cancer Inst       Date:  2022-05-09       Impact factor: 11.816

8.  Lockdown of Breast Cancer Screening for COVID-19: Possible Scenario.

Authors:  Gianluca Vanni; Marco Pellicciaro; Marco Materazzo; Valentina Bruno; Chiara Oldani; Chiara Adriana Pistolese; Chiara Buonomo; Jonathan Caspi; Paola Gualtieri; Agostino Chiaravalloti; Leonardo Palombi; Emilio Piccione; Oreste Claudio Buonomo
Journal:  In Vivo       Date:  2020 Sep-Oct       Impact factor: 2.155

9.  Breast cancer in European Union: an update of screening programmes as of March 2014 (review).

Authors:  E Altobelli; A Lattanzi
Journal:  Int J Oncol       Date:  2014-09-01       Impact factor: 5.650

10.  Cost-Effectiveness of Three Rounds of Mammography Breast Cancer Screening in Iranian Women.

Authors:  Shahpar Haghighat; Mohammad Esmaeil Akbari; Parvin Yavari; Mehdi Javanbakht; Shahram Ghaffari
Journal:  Iran J Cancer Prev       Date:  2016-02-23
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.